GALT
Galectin (GALT)
NASDAQ
$3.44+$0.32 (+10.19%)
Price as of Jun 23, 2026 7:59 PM EDT
  • $184.4M
    Market Cap
  • 28.93%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-14.3M
-60.93%
-36.6M
+13.82%
-32.1M
+1.24%
-31.7M
+33.25%
Depreciation and Amortization Expense
N/A
N/A
0
N/A
0
N/A
0
N/A
Total Operating Expenses
20.1M
-52.67%
42.4M
+11.45%
38.1M
-0.73%
38.4M
+27.08%
Operating Profit
-20.1M
-52.67%
-42.4M
+11.45%
-38.1M
-0.73%
-38.4M
+27.08%
Interest Income
126,000
-62.72%
338,000
+46.96%
230,000
+342.31%
52,000
+1,633.33%
Interest Expense
-154,000
-26.67%
-210,000
-92.48%
-2.8M
+170.28%
-1.0M
+111.25%
Interest Income and Expense and Net
-28,000
-121.87%
128,000
+105.00%
-2.6M
+161.16%
-981,000
+101.85%
Total Nonoperating Income and Expense
-10.8M
+133.01%
-4.6M
+54.11%
-3.0M
+606.13%
-424,000
+21.84%
Income before Taxes
-31.0M
-34.38%
-47.2M
+5.35%
-44.8M
+15.26%
-38.9M
+26.63%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-30.8M
-34.46%
-47.0M
+14.56%
-41.1M
+5.91%
-38.8M
+27.02%
Net Income from Continuing Operations Applicable to Common
-31.0M
-34.38%
-47.2M
+5.35%
-44.8M
+15.26%
-38.9M
+26.63%
Basic EPS and Net Income
-0.48
-36.84%
-0.76
+2.70%
-0.74
+13.85%
-0.65
+25.00%
Diluted EPS and Net Income
-0.48
-36.84%
-0.76
+2.70%
-0.74
+13.85%
-0.65
+25.00%
Basic Weighted Average Shares
63.9M
+2.56%
62.3M
+3.57%
60.2M
+1.29%
59.4M
+1.48%
Diluted Weighted Average Shares
63.9M
+2.56%
62.3M
+3.57%
60.2M
+1.29%
59.4M
+1.48%
Balance Sheet
Cash and Cash Equivalents
17.7M
+17.20%
15.1M
-41.08%
25.7M
+38.02%
18.6M
-53.11%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
17.7M
+17.20%
15.1M
-41.08%
25.7M
+38.02%
18.6M
-53.11%
Total Current Assets
19.4M
+12.66%
17.3M
-37.74%
27.7M
+34.83%
20.6M
-50.86%
Accumulated Depreciation
74,000
0.00%
74,000
0.00%
74,000
0.00%
74,000
0.00%
Property and Plant and Equipment and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Long-Term Assets
96,000
-60.49%
243,000
-50.41%
490,000
-33.15%
733,000
+10,371.43%
Total Assets
19.5M
+11.64%
17.5M
-37.96%
28.2M
+32.49%
21.3M
-49.11%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.0M
-77.32%
35.4M
+125.88%
15.7M
+20.47%
13.0M
+44.05%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
4.0M
N/A
0
-100.00%
20,000
-69.70%
66,000
N/A
Total Liabilities
145.7M
+20.87%
120.6M
+36.32%
88.4M
+65.38%
53.5M
+36.39%
Retained Earnings
-432.5M
+7.71%
-401.6M
+13.32%
-354.4M
+14.47%
-309.6M
+14.36%
Total Stockholders Equity
-127.9M
+22.07%
-104.8M
+69.12%
-62.0M
+82.69%
-33.9M
-3,898.10%
Total Shares Outstanding
65.2M
+3.24%
63.2M
+2.11%
61.9M
+4.08%
59.4M
+0.14%
Cash Flow
Cash from Operating Activities
-23.9M
-42.84%
-41.8M
+26.70%
-33.0M
+6.15%
-31.1M
+27.76%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
26.5M
-15.22%
31.2M
-22.00%
40.0M
+300.33%
10.0M
-72.84%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-166.56%
-19.11%
-205.92%
+24.07%
-165.97%
+35.07%
-122.88%
+43.76%
Return on Equity
26.50%
-53.03%
56.43%
-34.13%
85.66%
-63.52%
234.84%
+189.86%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.42
+396.80%
0.49
-72.44%
1.77
+11.92%
1.58
-65.88%
Cash Ratio
2.21
+416.79%
0.43
-73.91%
1.64
+14.56%
1.43
-67.45%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow